openPR Logo
Press release

CMO/CDMO Biotechnology Market 2022: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, and Forecast To 2031

06-27-2022 11:11 PM CET | Health & Medicine

Press release from: Persistence Market Research

CMO/CDMO Biotechnology Market 2022: Global Key Players,

The global CMO/CDMO biotechnology market was valued at over US$ 8.3 Bn in 2020, and is expected to exhibit a CAGR of around 11% over the forecast period (2021 - 2031).

A contract development and manufacturing CDMO provides development and manufacturing services to biotechnology/biopharmaceuticals companies. Pharma/biopharma and biotechnology companies partners with CDMOs as a way to outsource drug development and drug manufacturing.

Development services, bio manufacturing services, analytical testing, fill finishing, packaging, and clinical supply services are some of the services provided by biotechnology CDMOs/CMOs.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32516

With advancements in contract solutions, leading CDMOs are focusing on the expansion of their integrated capabilities from molecule-to-finished product. The trend is significant as the acceleration of development and the market is becoming more crucial for biopharmaceutical and biologics developers.

Leading industry players are focusing on the development and launch of next-generation bio therapeutics to treat serious life-threatening diseases. The current biologics-development pipeline supports an outlook of continued healthy growth. The number of biotech patents applied for every year has been growing at approximately 23% annually.

Company Profiles:

Patheon N.V.
Catalent
Samsung Biologics Co., Ltd
Boehringer Ingelheim
Samsung BioLogics
AGC Biologics, Inc.
Avid Bioservices, Inc.
Fujifilm Diosynth Biotechnologies
Xpress Biologic

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32516

Key Takeaways from Market Study

Standalone services hold around 57% value share, globally, primarily due to growing cell-line development services by biopharmaceutical and biotechnology companies.

Leading global CDMOs are focusing on expansion of their manufacturing capabilities with high flexibility and rapid operation. With the help of advanced single-use technologies, companies are able to cut batch manufacturing and cleaning time from 7 days to 1 day.

In terms of product, monoclonal antibodies are leading the market and are expected to hold 47% market share over the forecast period. This is owing to significant success rate of development and approval of both, bio-specific and antibody fragments.

The mammalian segment widely dominates at 80% share, owing to the capabilities to add human-like post-translational modifications to complex protein therapeutics.

By company size, mid-size contract development manufacturers accounted for the largest share of global CDMO/CMO biotechnology manufacturing. This is mainly because most of small operation CMOs have capabilities to produce enough antibodies.

Based on scale of operation, the commercial segment is leading with 50% market share, owing to increasing approvals of new bio therapeutics and their commercialization.

The region of North America is dominant in the global market for CMO/CDMO biotechnology, and will continue to remain the most lucrative market over the forecast period.

"Growing outsourcing to CMO/CDMOs and for monoclonal antibodies (mAbs), and technological upgrades to boost manufacturing are expected to drive the market over the coming years" says an analyst of Persistence Market Research.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32516

New Product Launches - Strategy by Key Players

Key manufacturers of CMO/CDMO biotechnology use the strategy of introducing new and innovative solutions. Moreover, they also focus on expanding their market with collaborations and acquisitions in key regions. This factor induces intense competition among market players.

For instance, in Oct 2018, Boehringer Ingelheim achieved a next-expansion milestone in biologics production in the U. S. The company invested €200 million. This expansion has increased the company's worldwide capacity for manufacturing biopharmaceutical medicines, which exceeds 290,000 liters.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the CMO/CDMO biotechnology market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.

The research study is based on service (standalone services and integrated development), product (monoclonal antibodies, antibody fragments, recombinant therapeutic proteins, viral vector, cell and gene therapy, and vaccines), platform/ expression system (mammalian, microbial, insect and others), company/ organization size (small, mid-sized, large, and very large), and scale of operation/application (preclinical, clinical, commercial, and others), across seven key regions of the world.

Access PMR Exclusive Reports-

Testing Inspection And Certification Market- https://www.persistencemarketresearch.com/market-research/testing-inspection-and-certification-market.asp

8K Technology Market- https://www.persistencemarketresearch.com/market-research/8k-technology-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CMO/CDMO Biotechnology Market 2022: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, and Forecast To 2031 here

News-ID: 2664285 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for CDMO

Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications. The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for